CCND1 G870A polymorphism is associated with increased risk of colorectal cancer, especially for sporadic colorectal cancer and in Caucasians: A meta-analysis

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 2, 2012, Pages 169-177

  Yang, Jing ^a   Zhang, Guoxin ^b   Chen, Jianping ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

ARTICLE; CANCER RISK; CAUCASIAN; COLON CANCER; COLORECTAL CANCER; EMBASE; ETHNICITY; FAMILY HISTORY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MEDICAL LITERATURE; MEDLINE; RECTUM CANCER; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

COLORECTAL NEOPLASMS; CYCLIN D1; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84862780063     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.11.007     Document Type: Article

References (45)

1. Sung.W.K., Lau J.J., Goh J.Y., Leung K.L. Increasing incidence of colorectal cancer in Asia: Implications for screening. Lancet Oncol 2005, 6(11):871-876.
2. Chia K., Seow K.S., Lee A., Gao H.P., Lee W., Shanmugaratnam H.P. Cancer incidence in Singapore 1993-1997. Sing Cancer Registry Rep 2000, 5:6-14.
3. Beart R.W., Steele GD, Menck H.R., Chmiel J.S., Ocwieja K.E., Winchester D.P. Management of survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Am Coll Surg 1995, 18(13):225-236.
4. Glade M.J. Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund. American Institute for Cancer Research, 1997. Nutrition 1999, 15(6):523-526.
5. Potter J.D. Colorectal cancer: molecules and populations. J. Natl Cancer Inst 1999, 91(11):916-932.
6. De la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004, 4(10):769-780.
7. Sherr C.J. Cancer cell-cycles. Science 1996, 274(5293):1672-1677.
8. Lin D.G., Beerm J. Molecular biology of upper gastrointestinal malignancies. Semin Oncol 2004, 31(4):476-486.
9. Correa M.C., Piazuelo P., Camargo M.B. Future of gastric cancer prevention. Gastric Cancer 2004, 7(1):9-16.
10. Cortessis M.C., Siegmund V.K., Xue K., Ross S., Yu R.K. A case-control study of cyclin D1 CCND1 870A-G polymorphism and bladder cancer. Carcinogenesis 2003, 24(10):1645-1650.
11. Yuan Q., Gu L., Shao X., Wang J., Wang M., Zhu M. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. DNA Cell Biol 2010, 29(10):611-617.
12. Yaylim-Eraltan O., Ergen I., Görmüs A., Arikan U., Küçücük S., Sahin S. Breast cancer and cyclin D1 gene polymorphism in Turkish women. In Vivo 2009, 23(5):767-772.
13. Krippl G., Langsenlehner P., Renner U., Yazdani-Biuki W., Wolf B., Wascher T.C. The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer. Breast Cancer Res Treat 2003, 82(3):165-168.
14. Gupta J.D., Feber V.K., Xi A., Pennathur L., Wu A., Luketich M. Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma. Clin Cancer Res 2008, 14(23):7804-7812.
15. Gautschi J., Ratschiller O., Gugger D., Betticher M., Heighway D.C. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 2007, 55(1):1-14.
16. Jia F., Gong A., Li J., Hao Y., Chang Z., Dai X. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China. Scand J Gastroenterol 2008, 43(11):1353-1359.
17. Tahara I., Arisawa T., Shibata T., Yamashita T., Hirata H. Associaction between Cyclin D1(CCND1) polymorphism and gastric cancer risk in japanese population. Hepatogastroenterology 2009, 56(93):1232-1235.
18. Le Marchand L., Seifried L., Lum-Jones A., Donlon A., Wilkens T. Association of the cyclin D1 L.R.A870G polymorphism with advanced colorectal cancer. J.A.M.A. 2003, 290(21):2843-2848.
19. Porter F., Richards T.R., Houlston F.M., Evans R.S., Jankowski D.G., Macdonald J.A. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 2002, 21(12):1928-1933.
20. Schernhammer G.A., Tranah E.S., Giovannucci G.J., Chan E., Ma A.T., Colditz J. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer 2006, 94(6):928-934.
21. Kong J., Wei S., Amos Q., Lynch C.I., Levin P.M., Zong B. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 2001, 93(14):1106-1108.
22. McKay J.A., Douglas J.J., Ross V.G., Curran S., Murray G.I., Cassidy J. Cyclin D1 protein expression and gene polymorphism in colorectal cancer Aberdeen Colorectal Initiative. Int J Cancer 2000, 88(1):77-81.
23. Liu X., Zhang B., Jin Y., Ni M., Liang Q., Ma X. Association of selected polymorphisms of CCND1, p21, and caspase 8 with colorectal cancer risk. Mol Carcinog 2010, 49(1):75-84.
24. Tan J., Nieters X.L., Kropp A., Hoffmeister S., Brenner M., Chang-Claude H. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case-control study and meta-analysis. Int. J. Cancer 2008, 122(11):2573-2580.
25. Probst-Hensch M.C., Sun N.M., Van Den Berg C.L., Ceschi D., Koh M., Yu W.P. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis 2006, 27(12):2475-2482.
26. Grieu B., Malaney F., Ward S., Joseph R., Iacopetta D. Lack of Association Between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res 2003, 23(5b):4257-4259.
27. Hong P.Y., Eu Y., Seow-Choen K.W., Fook-Chong F., Cheah S. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. Eur J Cancer 2005, 41(7):1037-1044.
28. Jiang Y., Wang J., Suzuki J., Gajalakshmi S., Kuriki V., Zhao K. Elevated risk of colorectal cancer associated with the AA genotype f the cyclin D1 A870G polymorphism in an Indian population. J Cancer Res Clin Oncol 2006, 132:193-199.
29. Forones I.D., de Lima N.M., de Souza J.M., da Silva L.G. Cyclin D1 A870G polymorphism in brazilian colorectal cancer patients. J Gastrointest Cancer 2008, 39(1-4):118-123.
30. Krüger M.K., Engel S., Bier C., Mangold A., Pagenstecher E., Doeberitz C. Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer. Cancer Lett 2006, 236(2):191-197.
31. Grünhage H., Jungck F., Lamberti M., Berg C., Becker C., Schulte-Witte U. Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis 2008, 23(2):147-154.
32. Huang J.M., Tang W.S., Lin R., Changchien P.Y., Chen C.R., Chiang J.S. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan. Dis Colon Rectum 2006, 49(5):602-608.
33. Yaylim-Eraltan E., Arikan I., Yildiz S., Cacina Y., Ergen C., Tuna H.A. The Influence of Cyclin D1 A870G Polymorphism on colorectal cancer risk and prognosis in a turkish population. Anticancer Res 2010, 30(7):2875-2880.
34. Lewis M.F., Bostick R.C., Xie R.M., Deng D., Wargovich Z., Fina M.J. Polymorphism of the Cyclin D1 Gene CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res 2003, 63(23):8549-8553.
35. Talseth J., Ashton B.A., Meldrum K.A., Suchy C., Kurzawski J., Lubinski G. Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Int J Cancer 2008, 122(6):1273-1277.
36. Solomon Z., Wang D.A., Fox Y., Lambeck S.R., Giesting T.C., Lan S. Cyclin D1 splice variants differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 2003, 278(32):30339-30347.
37. Lu J.A., Gladden F., Diehl A.B. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 2003, 63(21):7056-7061.
38. Betticher J., Thatcher D.C., Altermatt N., Hoban H.J., Ryder P., Heighway W.D. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995, 11(5):1005-1011.
39. Sherr C.J. Cell-cycle control and cancer. Harvey Lect 2000-2001, 96:73-92.
40. Adams P.D. Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim Biophys Acta 2001, 1471(3):M123-M133.
41. Knudsen E.S., Alan Diehl K.E., Haiman J., Knudsen C.A. CyclinD1 polymorphism, aberrant splicing and cancer risk. Oncogene 2006, 25:1620-1628.
42. Lévêque B., Marsaud C., Renoir V., Sola J.M. Alternative cyclin D1 forms a and b have different biological functions in the cell-cycle of B lymphocytes. Exp Cell Res 2007, 313(12):2719-2729.
43. Pabalan N., Bapat B., Sung L., Jarjanazi H., Francisco-Pabalan O., Ozcelik H. Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17(10):2773-2781.
44. Chen X.T., Cao B., Yang L., Zhou P., Wu Y. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: A meta-analysis comprising 20,271 subjects. Cancer Epidemiol 2011.
45. Zambirinis M., Theodoropoulos C.P., Gazouli G. Undefined familial colorectal cancer. World J Gastrointest Oncol 2009, 1:12-20.